US Patent Issued to PRIMO PHARMATECH on March 31 for "Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient" (New Jersey Inventor)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,095, issued on March 31, was assigned to PRIMO PHARMATECH LLC (Somerset, N.J.).

"Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient" was invented by Zheng Wang (Bridgewater, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel unit dosage form for oral transmucosal delivery of an active pharmaceutical ingredient (API). The dosage form contains a permeation enhancer that promotes fast absorption, rapid onset of action, and overall high bio availability for the API."

The patent was filed on May 29, 2020, under Application No. 17/610,965.

*For further information, including images, charts and tables, please...